Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pain"
DOI: 10.1002/ejp.1147
Abstract: There is considerable public and political interest in the use of cannabis products for medical purposes. read more here.
Keywords: cannabis; availability approval; cannabis based; based medicines ... See more keywords
European Pain Federation (EFIC) position paper on appropriate use of cannabis‐based medicines and medical cannabis for chronic pain management
Sign Up to like & getrecommendations! Published in 2018 at "European Journal of Pain"
DOI: 10.1002/ejp.1297
Abstract: Cannabis‐based medicines are being approved for pain management in an increasing number of European countries. There are uncertainties and controversies on the role and appropriate use of cannabis‐based medicines for the management of chronic pain.… read more here.
Keywords: cannabis; cannabis based; based medicines; use cannabis ... See more keywords
Face validity of the ICD‐10 criteria of substance abuse and dependence for patients prescribed cannabis‐based medicines for chronic pain—A survey of pain medicine physicians in Canada, Germany and Israel
Sign Up to like & getrecommendations! Published in 2023 at "European Journal of Pain"
DOI: 10.1002/ejp.2082
Abstract: A major concern with cannabis‐based medicines (CbM) and medical cannabis (MC) is the risk of abuse and dependence. The face validity of the International Classification of Diseases (ICD‐10) criteria for cannabis dependence in patients prescribed… read more here.
Keywords: abuse dependence; cannabis based; pain; medicine ... See more keywords
Barriers to prescribing cannabis‐based medicines
Sign Up to like & getrecommendations! Published in 2019 at "Prescriber"
DOI: 10.1002/psb.1774
Abstract: Last November, the government moved cannabis‐based medicinal products out of Schedule 1 into Schedule 2 of the Misuse of Drugs Regulations, meaning they can now legally be prescribed. However, conflicting advice from different authorities, sourcing… read more here.
Keywords: prescribing cannabis; based medicines; barriers prescribing; cannabis based ... See more keywords
NICE on the use of cannabis‐based medicinal products
Sign Up to like & getrecommendations! Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1838
Abstract: This article provides a summary of the recent NICE recommendations on the use of cannabis‐based medicinal products (CBMPs) in the treatment of epilepsy, spasticity, pain, and nausea and vomiting. It also discusses the guidance on… read more here.
Keywords: based medicinal; medicinal products; cannabis based; use cannabis ... See more keywords
Comment on: Cannabis use among Danish patients with cancer: a cross‑sectional survey of sociodemographic traits, quality of life, and patient experiences
Sign Up to like & getrecommendations! Published in 2022 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-022-06995-7
Abstract: The recent article by Nielsen and colleagues [1] presents an interesting cross-sectional investigation on a subgroup of cancer patients that self-prescribed cannabinoids. The authors present a study with a high response rate (83%) among the… read more here.
Keywords: cancer; nielsen colleagues; cross sectional; cannabis ... See more keywords
Adverse events associated with the use of cannabis-based products in people living with cancer: a systematic scoping review
Sign Up to like & getrecommendations! Published in 2024 at "Supportive Care in Cancer"
DOI: 10.1007/s00520-024-09087-w
Abstract: To summarise the extent and type of evidence in relation to adverse events (AEs) associated with the use of cannabis-based products (CBP) in people living with cancer. The Joanna Briggs Institute (JBI) methodology for scoping… read more here.
Keywords: cancer; adverse events; use cannabis; associated use ... See more keywords
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
Sign Up to like & getrecommendations! Published in 2021 at "CNS Drugs"
DOI: 10.1007/s40263-021-00879-w
Abstract: Neuropathic pain represents a broad category of pain syndromes that include a wide variety of peripheral and central disorders. The overall prevalence of neuropathic pain in the general population is reported to be between 7… read more here.
Keywords: chronic neuropathic; cannabis based; based medicines; neuropathic pain ... See more keywords
Cannabis-Based Medicines and Medical Cannabis in Rheumatic Diseases: A Treasure Chest or Pandora’s box
Sign Up to like & getrecommendations! Published in 2019 at "Current Treatment Options in Rheumatology"
DOI: 10.1007/s40674-019-00130-0
Abstract: Interest in cannabinoids as a therapy in rheumatic diseases has grown exponentially. With legalization of medical and recreational cannabis in many jurisdictions worldwide, patients have easier access and opportunity to explore medicinal use. We report… read more here.
Keywords: cannabis; rheumatic diseases; cannabis based; rheumatology ... See more keywords
Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry
Sign Up to like & getrecommendations! Published in 2022 at "Neuropediatrics"
DOI: 10.1055/a-2002-2119
Abstract: Abstract Background There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. Methods A case series of children ( read more here.
Keywords: cannabis; cannabis based; medicinal products; based medicinal ... See more keywords
A Multicriteria Decision Analysis Comparing Pharmacotherapy for Chronic Neuropathic Pain, Including Cannabinoids and Cannabis-Based Medical Products.
Sign Up to like & getrecommendations! Published in 2021 at "Cannabis and cannabinoid research"
DOI: 10.1089/can.2020.0129
Abstract: Background: Pharmacological management of chronic neuropathic pain (CNP) still represents a major clinical challenge. Collective harnessing of both the scientific evidence base and clinical experience (of clinicians and patients) can play a key role in… read more here.
Keywords: pain; chronic neuropathic; neuropathic pain; decision ... See more keywords